The combination of encorafenib and binimetinib for the treatment of patients with BRAF-mutated advanced, unresectable, or metastatic melanoma: an update

Authors

Erin McClure, Lehigh Valley Health NetworkFollow
Ayushi Y. Patel, Lehigh Valley Health NetworkFollow
M J. Carr
J Sun
J S. Zager

Publication/Presentation Date

1-2021

Volume

6

Issue

1

First Page

19

Last Page

29

Published In/Presented At

McClure, E., Patel, A., Carr, M. J., Sun, J., & Zager, J. S. (2021). The combination of encorafenib and binimetinib for the treatment of patients with BRAF-mutated advanced, unresectable, or metastatic melanoma: an update. Expert Review of Precision Medicine and Drug Development, 6(1), 19–29. https://doi.org/10.1080/23808993.2021.1847639

Disciplines

Medical Education | Medicine and Health Sciences

Department(s)

USF-LVHN SELECT Program, USF-LVHN SELECT Program Students

Document Type

Article